UCP2 and central nervous system cancer: More notably, in an analysis of Kaplan-Meyer curves based on gene expression the TCGA GBMLGG shows that, across low- and high-grade gliomas, higher UCP2 expression is associated with significantly shorter median survival when compared to low UCP2 expression (High=26.4, Low=87.5 months, Figure 1D).